Risk factors in elderly people for lentigo maligna compared with other melanomas: A double case-control study

Archives of Dermatology

Volumn 145, Issue 4, 2009, Pages 418-423

  Gaudy Marqueste, Caroline ^a   Madjlessi, Nika ^a   Guillot, Bernard ^c   Avril, Marie Françoise ^b   Grob, Jean Jacques ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b HÔPITAL SAINT ELOI   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CONTROLLED STUDY; CUTANEOUS PARAMETERS; FEMALE; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; NEVUS; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SKIN COLOR; SKIN DEFECT; SKIN EXAMINATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE;

AGED; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; MELANOMA; NEOPLASMS, RADIATION-INDUCED; NEVUS; PHENOTYPE; PRECANCEROUS CONDITIONS; RISK FACTORS; SKIN NEOPLASMS; SUNBURN; SUNLIGHT;

EID: 65349091327     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.1     Document Type: Article

References (24)

1. McHenry PM, Hole DJ, MacKie RM. Melanoma in people aged 65 and over in Scotland, 1979-89. BMJ. 1992;304(6829):746-749.
2. Richard MA, Grab JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer. 2000;89(3):271-279.
3. Lasithiotakis K, Leiter U, Meier F, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer. 2008; 112(8):1795-1804.
4. Cox NH, Aitchison TC, Sirel JM, MacKie RM; Scottish Melanoma Group. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer. 1996;73(7):940-944.
5. Holman CD, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res. 1986;102:18-37.
6. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a casecontrol study in Ontario, Canada. Int J Epidemiol. 1999;28(3):418-427.
7. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95(24):1878-1890.
8. Sasaki Y, Niu C, Makino R, et al. BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol. 2004;123(1)177-183.
9. Larnier C, Ortonne JP, Venot A, et al. Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol. 1994;130(2):167-173.
10. Grab JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer. 1990;66(2):387-395.
11. Dubin N, Moseson M, Pasternack BS. Epidemiology of malignant melanoma: Pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. In: Gallagher RP, ed. Recent Results in Cancer Research. Vol 102. New York, NY: Springer-Verlag; 1986:56-75.
12. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol.1988;124(6):869-871.
13. Elwood JM, Diffey BL. A consideration of ambient solar ultraviolet radiation in the interpretation of studies of the aetiology of melanoma. Melanoma Res. 1993; 3(2):113-122.
14. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II, sun exposure. Eur J Cancer. 2005;41(1):45-60.
15. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I, common and atypical naevi. Eur J Cancer. 2005;41(1):28-44.
16. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst. 1987;78(1):37-44.
17. Siskind V, Whiteman DC, Aitken JF, Martin NG, Green AC. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Causes Control. 2005;16(3):193-199.
18. Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95(11):806-812.
19. Purdue MP, From L, Armstrong BK, et al; Genes, Environment, and Melanoma Study Group. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2005;14(8): 2015-2022.
20. Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN. Photoaging: mechanisms and repair. J Am Acad Dermatol. 2006;55(1):1-19.
21. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135-2147.
22. Fariñas-Alvarez C, Ródenas JM, Herranz MT, Delgado-Rodríguez M. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol. 1999;140(3):457-462.
23. Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000;88(12):2703-2710.
24. Ming ME, Levy RM, Hoffstad OJ, Filip J, Gimotty PA, Margolis DJ. Validity of patient self-reported history of skin cancer. Arch Dermatol. 2004;140(6):730-735.